Zinke; Paul W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zinke; Paul W..The latest application filed is for "(r)-8,9-dichloro-2,3,4,4a-tetrahydro-1h,6h-pyrazino[1,2-a]quinoxalin-5-one for controlling iop and treating glaucoma".

Company Profile

0.12.6

Zinke; Paul W. - Fort Worth TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(R)-8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one for controlling IOP and treating glaucoma App 20060211700 - May; Jesse A. ; et al.	2006-09-21
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma Grant 6,933,392 - May , et al. August 23, 2	2005-08-23
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma Grant 6,884,816 - May , et al. April 26, 2	2005-04-26
5-Hydroxyl indole derivatives for treating glaucoma Grant 6,806,285 - May , et al. October 19, 2	2004-10-19
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension App 20040198817 - Klimko, Peter G. ; et al.	2004-10-07
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 6,723,748 - Klimko , et al. April 20, 2	2004-04-20
15-fluoro prostaglandins as ocular hypotensives Grant 6,680,339 - Klimko , et al. January 20, 2	2004-01-20
15-fluoro prostaglandins as ocular hypotensives Grant 6,649,653 - Klimko , et al. November 18, 2	2003-11-18
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma App 20030181504 - May, Jesse A. ; et al.	2003-09-25
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma App 20030181503 - May, Jesse A. ; et al.	2003-09-25
Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma App 20030083346 - May, Jesse A. ; et al.	2003-05-01
15-fluoro prostaglandins as acular hypotensives App 20020151587 - Klimko, Peter G. ; et al.	2002-10-17
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension Grant 6,353,000 - Sallee , et al. March 5, 2	2002-03-05
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 6,184,250 - Klimko , et al. February 6, 2	2001-02-06
Conformationally rigid aryl prostaglandins for use in glaucoma therapy Grant 6,169,111 - Zinke , et al. January 2, 2	2001-01-02
substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives Grant 6,025,392 - Selliah , et al. February 15, 2	2000-02-15
Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension Grant 5,889,052 - Klimko , et al. March 30, 1	1999-03-30
Preparation of carbonic anhydrase inhibitors Grant 5,473,067 - Dean , et al. December 5, 1	1995-12-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.